Gracell biotechnologies

About Gracell Biotechnologies Inc:

Gracell Biotechnologies Inc. is a global clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough cell therapies. Leveraging its pioneering FasTCAR and TruUCAR technology platforms, Gracell is developing a rich clinical-stage pipeline of multiple autologous and allogeneic product candidates with the potential to overcome major industry challenges that persist with conventional CAR-T therapies, including lengthy manufacturing time, suboptimal production quality, high therapy cost and lack of effective CAR-T therapies for solid tumors.

Company Name:

Gracell Biotechnologies Inc

Gracell Biotechnologies Founded:

Gracell Biotechnologies Inc founded in 2017

Gracell Biotechnologies size:

There are 160 employee on this company in Shangai.

Gracell Biotechnologies Revenue:

Gracell Biotechnologies revenue for 2021 was about $54 Million.

Gracell Biotechnologies products and Services:

Gracell Biotechnologies is developing cell and gene therapies by high tech solutions for personal medicine

Gracell Biotechnologies :www.gracellbio.com

Gracell Biotechnologies location:

Shangai, China

Gracell Biotechnologies phone number:

+86 21 6403 1375

Gracell Biotechnologies stocks:

GRCL (NASDAQ)

Gracell Biotechnologies CEO:

William Cao

Gracell Biotechnologies profile on social media:

https://www.linkedin.com/company/gracellbio/

Top references about the Gracell Biotechnologies portfolio:

https://www.nasdaq.com/market-activity/stocks/grcl/revenue-eps

%d bloggers like this: